...
首页> 外文期刊>Journal of Clinical Immunology >Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.
【24h】

Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.

机译:肺结核患者血浆中1,25二羟基维生素D3的水平以及维生素D受体和cathelicidin的表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: Vitamin D(3), which exerts its effect through vitamin D receptor (VDR), is known for its potent immunomodulatory activities. Associations between low serum vitamin D(3) levels and increased risk of tuberculosis have been reported. STUDY SUBJECTS AND METHODS: Plasma 1,25 dihydroxy vitamin D(3) levels (1,25(OH)(2) D(3)) and ex vivo levels of VDR protein from peripheral blood mononuclear cells were studied in 65 pulmonary tuberculosis (PTB) patients and 60 normal healthy subjects (NHS) using enzyme-linked immunosorbent assay-based methods. Using real-time polymerase chain reaction (PCR), induction of VDR, cathelicidin, and CYP27B1 mRNA were studied in live Mycobacterium tuberculosis-stimulated macrophage cultures treated with or without 1,25 dihydroxy vitamin D(3). VDR and CYP27B1 (-1077 A/T) gene polymorphisms were studied using PCR-based methods. RESULTS: 1,25(OH)(2) D(3) were significantly increased (p = 0.0004), while ex vivo levels of VDR protein were significantly decreased in PTB patients (p = 0.017) as compared to NHS. 1,25(OH)(2) D(3) levels were not different between variant genotypes of CYP27B1. A trend towards decreased levels of VDR protein was observed among NHS with BsmI BB and TaqI tt genotypes compared to NHS with other genotypes. Relative quantification of mRNA using real-time PCR revealed increased VDR mRNA expression in live M. tuberculosis-stimulated culture in PTB patients (p < 0.01) than normal healthy subjects. Cathelicidin mRNA expression was significantly increased in vitamin D(3)-treated cultures compared to unstimulated and M. tuberculosis-stimulated culture in both patients (p < 0.001) and NHS (p < 0.05). CONCLUSIONS: The present study suggests that PTB patients may have increased 1,25(OH)(2) D(3) levels, and this might lead to downregulation of VDR expression. Decreased VDR levels could result in defective VDR signaling. Moreover, addition of 1,25(OH)(2) D(3) might lead to increased expression of cathelicidin which could enhance the immunity against tuberculosis.
机译:简介:维生素D(3)通过维生素D受体(VDR)发挥作用,以其强大的免疫调节活性而闻名。低血清维生素D(3)水平与结核病风险增加之间的关联已有报道。研究对象和方法:在65例肺结核患者中研究了血浆1,25二羟基维生素D(3)水平(1,25(OH)(2)D(3))和离体水平来自外周血单个核细胞的VDR蛋白。 PTB)患者和60名正常健康受试者(NHS)使用基于酶联免疫吸附测定的方法。使用实时聚合酶链反应(PCR),在有或没有1,25二羟基维生素D(3)处理的活结核分枝杆菌刺激的巨噬细胞培养物中研究了VDR,cathelicidin和CYP27B1 mRNA的诱导。使用基于PCR的方法研究了VDR和CYP27B1(-1077 A / T)基因多态性。结果:与NHS相比,PTB患者的1,25(OH)(2)D(3)显着增加(p = 0.0004),而离体VDR蛋白水平显着降低(p = 0.017)。 CYP27B1的不同基因型之间的1,25(OH)(2)D(3)水平没有差异。与其他基因型的NHS相比,在BsmI BB和TaqI tt基因型的NHS中观察到VDR蛋白水平降低的趋势。使用实时PCR对mRNA的相对定量显示,与正常健康受试者相比,PTB患者在活的结核分枝杆菌刺激的培养物中VDR mRNA表达增加(p <0.01)。与未刺激和结核分枝杆菌刺激的培养相比,维生素D(3)处理的培养物中的Cathelicidin mRNA表达显着增加(p <0.001)和NHS(p <0.05)。结论:本研究提示PTB患者可能升高了1,25(OH)(2)D(3)水平,这可能导致VDR表达下调。 VDR级别降低可能会导致VDR信令有缺陷。此外,添加1,25(OH)(2)D(3)可能会导致cathelicidin的表达增加,从而增强抵抗结核病的免疫力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号